Drug

Benidipine

As of the edition of 20 October 2026, Benidipine is a small molecule: of no established status; acts on CACNA1C, CACNA1D and CACNA1F and 1 more.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Status not established
Kind
Small molecule
Registered trials
2, 0 stopped early
Disease areas
Heart and blood vessels; Pregnancy and women's health; Urinary and reproductive

US protection

No US approval on record.

With no US approval on record there are no listed US patents or exclusivities.

This is the US only.

Targets

GeneProteinUniProt
CACNA1FVoltage-dependent L-type calcium channel subunit alpha-1FO60840
CACNA1DVoltage-dependent L-type calcium channel subunit alpha-1DQ01668
CACNA1SVoltage-dependent L-type calcium channel subunit alpha-1SQ13698
CACNA1CVoltage-dependent L-type calcium channel subunit alpha-1CQ13936

Registered trials

PhaseTrialsCompletedActiveStopped early
Phase not stated1010
Phase 41000
All trials2